tizanidine
- Product NDC
- 50090-7716
- 11-digit product format
- 500907716
- Labeler code
- 50090
- Product ID
- 50090-7716_9edb8ad4-7e86-4eb9-b5b9-466b466c3fe7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA218920
- Marketing category
- ANDA
- Marketing start
- 2024-12-15
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- tizanidine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TIZANIDINE HYDROCHLORIDE | 2 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | B53E3NMY5C |
| Rxcui | 313412 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-7716-0 | tizanidine | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
| 50090-7716-1 | tizanidine | 60 in 1 BOTTLE | TABLET | 60 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-7716-0 | 50090771600 | 30 TABLET in 1 BOTTLE (50090-7716-0) | 30 tablet | 2025-10-15 | No | No | Current |
| 50090-7716-1 | 50090771601 | 60 TABLET in 1 BOTTLE (50090-7716-1) | 60 tablet | 2025-10-15 | No | No | Current |